Skip to main content
. 2019 Feb 18;16(4):589. doi: 10.3390/ijerph16040589

Table 4.

Incidence and hazard ratio of mortality compared among PTE patients with different number of AED (anti-epileptic drug) use and compared to PTN.

Variables n Event Person-Years Rate Crude HR
(95% CI)
Adjusted HR a
(95% CI)
Crude HR
(95% CI)
Adjusted HR a
(95% CI)
Posttraumatic nonepilepsy 1425 252 9126 27.6 1(Reference) 1(Reference)
Posttraumatic epilepsy
Without antiepileptic drug 42 5 289 17.3 0.63 (0.26, 1.55) 0.83 (0.34, 2.01) 1 (Reference) 1 (Reference)
One antiepileptic drug 219 68 1433 47.4 1.73 (1.32, 2.26) *** 2.05 (1.56, 2.69) *** 2.70 (1.09, 6.69) * 2.48 (0.99, 6.18)
Two antiepileptic drugs 515 198 2846 69.6 2.48 (2.06, 2.99) *** 2.28 (1.87, 2.78) *** 3.85 (1.58, 9.34) ** 2.89 (1.18, 7.07) *
More than two antiepileptic drugs 649 263 2870 91.6 3.13 (2.63, 3.72) *** 2.63 (2.17, 3.19) *** 4.78 (1.97, 11.6) *** 3.30 (1.35, 8.08) **

Rate: Per 1000 person-years; HR: Relative hazard ratio; a Adjusted for age, sex, alcohol-related illness, anxiety, mental disorders, insomnia, depression, stroke, COPD, CAD, diabetes, hypertension, and hyperlipidemia; * p < 0.05, ** p < 0.01, *** p < 0.001. Antiepilepsy drug including potassium clorazepate, phenobarbital, diazepam, zonisamide, valproic acid, topiramate, tiagabine, pregabalin, oxcarbazepine, levetiracetam, lamotrigine, gabapentin, carbamazepine, phenytoin, clonazepam, and primidone.